The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The predetermined value is set to a value of not higher than a minimum electricity generation temperature of the fuel cell, and a circulation timing and flow rate of the coolant for the aftercooler are controlled such that the supplied oxidizing gas does not become cold. 2 by screening of phage display libraries or monkey heterohybridomas obtained using B lymphocytes from B7. The embodiment is configured such that the charging cost circuit is to turn on the charging circuit during a first time period in which the charging cost rate is below a first threshold until the battery reaches a first energy stored level, and to turn on the charging circuit during a second time period in which the charging cost rate is above the first threshold. A comparison device compares the information development table with the accumulative information development table, and outputs a comparison result. The lock member sets and include secured members provided on the opening and closing member, and bearing members that are provided on the apparatus frame for elastically securing the secured members.